Saltar al contenido principal

Progress in Medicinal Chemistry

  • 1 Edición, Volumen 29 - 2 de marzo de 1992
  • Última edición
  • Editores: G. P. Ellis, D.K. Luscombe
  • Idioma: Inglés

The 29th volume of the series presents yet again, an exemplary survey of a wide range of current topics in medicinal chemistry and pharmacology. Eight expert reviews emphasize th… Leer más

Descripción

The 29th volume of the series presents yet again, an exemplary survey of a wide range of current topics in medicinal chemistry and pharmacology. Eight expert reviews emphasize the relationships between chemical structure and pharmacological activity. These detailed discussions of some of the most exciting developments in the field today, will prove of great value to future research. The book begins with a study of anti-inflammatory activities of 5-lipoxygenase inhibitors, followed by an overview of the antiarrhythmic therapeutic possibilities offered by Class III electrophysiological agents. Structures and activities of some opioid ligands are surveyed, and the investigation into pharmacologically active pyridazine derivatives is continued. Dopamine D2 receptor agonists offer exciting therapeutic potential, as do ondansetron and related 5-HT 3 antagonists. The herbal origin of many modern drugs is yet again reflected in a survey of the herb feverfew. The volume concludes, as it began, with enzyme inhibition - in this case concerning synthetic inhibitors of interstitial collagenases.

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 29
  • Publicado: 2 de marzo de 1992
  • Idioma: Inglés

Sobre los editores

GE

G. P. Ellis

Afiliaciones y experiencia
Department of Chemistry, University of Wales Institute of Science and Technology. King Edward VII Avenue, Cardiff

DL

D.K. Luscombe

Afiliaciones y experiencia
Welsh School of Pharmacy, University of Wales

Ver libro en ScienceDirect

Lee Progress in Medicinal Chemistry en ScienceDirect